Larvol Delta - Viracta-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results-and-Provides-a-Corporate-Update

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

nanatinostat (VRx-3996) - Viracta Therap

https://www.prnewswire.com/news-releases/viracta-therapeutics-reports-fourth-quarter-and-full-year-2021-financial-results--and-provides-a-corporate-update-301503692.html

Mar 16, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next